Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified

NACompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

October 1, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2018

Conditions
Cystic Fibrosis
Interventions
DRUG

Ceftazidime

DRUG

Tobramycin

Trial Locations (1)

Unknown

University College Cork, Cork

All Listed Sponsors
collaborator

Queen's University, Belfast

OTHER

collaborator

University of Paris 5 - Rene Descartes

OTHER

collaborator

University of Dundee

OTHER

collaborator

University of Washington

OTHER

collaborator

University Hospital Heidelberg

OTHER

collaborator

Teagasc

INDUSTRY

collaborator

Clininfo S.A.

INDUSTRY

collaborator

GABO:mi

INDUSTRY

collaborator

Papworth Hospital NHS Foundation Trust

OTHER_GOV

collaborator

KU Leuven

OTHER

collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

collaborator

European Union

OTHER

lead

University College Cork

OTHER

NCT02526004 - Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified | Biotech Hunter | Biotech Hunter